Compare IX & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IX | MDLN |
|---|---|---|
| Founded | 1950 | 1966 |
| Country | Japan | United States |
| Employees | 51921 | 45000 |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1B | 34.1B |
| IPO Year | N/A | N/A |
| Metric | IX | MDLN |
|---|---|---|
| Price | $30.01 | $44.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $50.48 |
| AVG Volume (30 Days) | 424.7K | ★ 6.5M |
| Earning Date | 05-11-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.60% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.82 | $10.83 |
| Revenue Next Year | $5.97 | $7.68 |
| P/E Ratio | ★ $12.93 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.75 | $38.50 |
| 52 Week High | $37.04 | $50.88 |
| Indicator | IX | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 54.81 |
| Support Level | $29.41 | $43.04 |
| Resistance Level | $30.82 | $46.90 |
| Average True Range (ATR) | 0.55 | 1.37 |
| MACD | -0.04 | 0.19 |
| Stochastic Oscillator | 52.43 | 98.94 |
ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.